将投中网设为"星标⭐"，第一时间收获最新推送 本期带来2025年半年度IPO报告，中金资本战绩居首，港主板账面退出回报最高。 作者丨 投中研究院 来源丨 超越 J Curve 以下文章来源于超越 J Curve ，作者超越J曲线 超越 J Curve . 用数据延伸你的阅读 核心发现 2025年上半年，共73家具有VC/PE背景的中企成功IPO，VC/PE机构IPO渗透率为 55.73%。中金资本参投7家企业，IPO战绩夺魁；红杉中国参投6家，位列第二；华金资本、 君联资本参投5家，并列第三； | 机构 | | 上市数量 科创数量 | | | 参投项目 | | | --- | --- | --- | --- | --- | --- | --- | | 中金资本 | 7 | 1 | 脑动极光 | 兴福电子 | 汉朔科技 | 正力新能 | | | | | 映恩生物 | Circle | 云知声 | | | 红杉中国 | 6 | 1 | 古茗 | 找钢集团 | 维异药业 | 微牛 | | | | | 汉邦科技 | 手回集团 | | | | 安全资本 | 5 | 2 | 钧威电子 | 江南新材 | 首航新能 | 汉邦 ...

2025.07. 13 本文字数：2103，阅读时长大约3分钟 作者 | 第一财经 何涛 封图 | 李家超主持特首顾问团午餐会议，图为其中一场会议。来源：香港特别行政区新闻公报 上周，香港特区行政长官李家超一连三天（7月9日至11日）与特首顾问团举行午餐会，听取顾问团 成员就今年《施政报告》和香港整体发展的意见。 第一财经记者注意到，这是新一届（第二届）特首顾问团成员的首次会议。顾问团出现三位新成员， 分别为著名经济学家朱民、浙江强脑科技有限公司创始人韩璧丞及杭州宇树科技有限公司创始人王兴 兴——强脑科技和宇树科技都是"杭州六小龙"企业。 相应地，首届特首顾问团成员中的三人不再出现，分别是李嘉诚长子、长和集团主席李泽钜，华润集 团前董事长傅育宁，以及已经去世的商汤科技创始人汤晓鸥。顾问团继续保持34人阵容不变。 特首顾问团是李家超于2023年主导成立的高层次咨询组织，分为经济高质量与持续发展，创新与创 业，以及区域与环球协作三个小组。成员均为来自政、商、学、律界的翘楚，像香港特区前财政司司 长唐英年、太古集团主席白德利、阿里巴巴创始人之一蔡崇信、诺贝尔经济学奖得主迈克尔·斯彭斯 等。公开信息显示，首届顾问团至 ...

为香港股市"打广告"，吸引更多内地企业赴港上市及借道香港"出海"，算是李家超邀请"二小龙"的"附带收获" 上周，香港特区行政长官李家超一连三天（7月9日至11日）与特首顾问团举行午餐会，听取顾问团成员就今年《施政报告》和香港整体发展的意见。 第一财经记者注意到，这是新一届（第二届）特首顾问团成员的首次会议。顾问团出现三位新成员，分别为著名经济学家朱民、浙江强脑科技有限公司创始 人韩璧丞及杭州宇树科技有限公司创始人王兴兴——强脑科技和宇树科技都是"杭州六小龙"企业。 相应地，首届特首顾问团成员中的三人不再出现，分别是李嘉诚长子、长和集团主席李泽钜，华润集团前董事长傅育宁，以及已经去世的商汤科技创始人汤 晓鸥。顾问团继续保持34人阵容不变。 特首顾问团是李家超于2023年主导成立的高层次咨询组织，分为经济高质量与持续发展，创新与创业，以及区域与环球协作三个小组。成员均为来自政、 商、学、律界的翘楚，像香港特区前财政司司长唐英年、太古集团主席白德利、阿里巴巴创始人之一蔡崇信、诺贝尔经济学奖得主迈克尔·斯彭斯等。公开 信息显示，首届顾问团至少与李家超举行了三次正式会议。 李家超主持特首顾问团午餐会议，图为其中一场会议 ...

未平仓空单比（绝对值）较上一次减少最多为远东宏信（03360）、众安在线（06060）、荣昌生物 （09995），分别减少-1.62%、-1.55%、-1.32%。 前10大未平仓空仓比 | 股票名称 | 前次空仓数 | 本次空仓数 | 最新空仓比↓ | | --- | --- | --- | --- | | 药明康德(02359) | 8717.47 万股 | 8734.54 万股 | 22.57% | | 宁德时代(03750) | 2631.99 万股 | 2768.85 万股 | 17.76% | | 中远海控(01919) | 4.06 亿股 | 4.11 亿股 | 14.27% | | 赣锋锂业(01772) | 5001.51 万股 | 5166.20 万股 | 12.80% | | 山东黄金(01787) | 1.09 亿股 | 1.10 亿股 | 12.77% | | 绿叶制药(02186) | 4.62 亿股 | 4.75 亿股 | 12.64% | | 协鑫科技(03800) | 33.24 亿股 | 35.43 亿股 | 12.44% | | 万科企业(02202) | 2.80 亿股 ...

Investment Rating - The report maintains a "Buy" rating for CATL A/H shares with a 12-month price target of Rmb 323.00 for A-shares and HK$ 411.00 for H-shares, indicating an upside of 19.3% and 6.8% respectively [8][15]. Core Insights - The report highlights three key focuses for CATL: unit gross profit (GP) expansion, upward trend in capital expenditures (CAPEX), and progress in the US market which may enhance the total addressable market (TAM) [15][16]. Summary by Sections Earnings Preview - CATL is expected to report revenue of Rmb 104.7 billion and net profit of Rmb 15.6 billion in 2Q25, with unit GP anticipated to increase to Rmb 150/kWh from Rmb 147/kWh in 1Q25, driven by strong overseas shipments [1][41]. Unit GP Expansion - The blended battery unit GP is projected to expand due to improved product mix, with overseas EV sales in Europe showing a 28% year-over-year growth in the first five months of 2025 [1][19]. CATL is estimated to account for about 70% of Europe's battery imports from China [1][20]. CAPEX Trends - The report revises up CAPEX forecasts for 2025-2027 by 25%-5%, expecting CATL's relative CAPEX share to rise from approximately 13% in 2024 to around 24% in 2025, which is expected to drive market share gains [16][30]. US Market Progress - Recent developments regarding Ford's Michigan LFP battery factory, which utilizes CATL's technology, suggest improved market access for CATL in the US, potentially increasing its TAM [16][19]. Financial Projections - Revenue projections for CATL are set at Rmb 362 billion for 2024, Rmb 436 billion for 2025, and Rmb 532 billion for 2026, with EBITDA expected to grow significantly over the same period [3][13]. EPS is forecasted to increase from Rmb 11.58 in 2024 to Rmb 22.45 by 2027 [3][13]. Market Position - CATL's market capitalization is noted at Rmb 1.2 trillion, with a strong enterprise value of Rmb 972.5 billion, indicating robust financial health and market positioning within the battery industry [3][5].

Group 1 - The A-share market shows signs of recovery, with the Shanghai Composite Index surpassing 3,500 points, attracting attention to foreign capital movements, particularly northbound funds [1] - As of the end of Q2 2025, northbound funds held a total of 2,907 A-shares, with a total shareholding of 1,232.08 billion shares, an increase of 41.19 billion shares from the previous quarter and 7.22 billion shares from the end of 2024 [2] - The total market value of northbound funds reached 2.289 trillion yuan, an increase of 537 billion yuan from the previous quarter and 871 billion yuan from the end of 2024, indicating a significant increase in investment in the A-share market [2] Group 2 - The industry with the largest increase in shareholding by northbound funds in Q2 2025 was enterprise services, with a growth of 38%, followed by telecommunications services at 27% and national defense at 26% [2] - Conversely, the industries with the largest decrease in shareholding were hardware equipment, down 15%, and home appliances and textiles, both down 13% [2] Group 3 - The stocks with the highest market value held by northbound funds as of June 2025 included CATL, Kweichow Moutai, Midea Group, and others, with CATL and Kweichow Moutai each exceeding 100 billion yuan in market value [3] - The three companies with the most significant changes in market value held by northbound funds were CATL, Hengrui Medicine, and Dongpeng Beverage, all of which have recently listed on the Hong Kong Stock Exchange [3][4] Group 4 - The decline in AH share premiums indicates a narrowing price gap between A-shares and H-shares, enhancing market efficiency and providing a fairer investment environment [5][7] - The decrease in AH share premiums may influence the allocation of northbound funds between A-shares and H-shares, shifting focus towards the fundamentals and industry outlook rather than short-term price differences [7][8]

Core Viewpoint - The recent announcement by President Trump regarding potential high tariffs on copper and pharmaceuticals has led to a decline in Hong Kong's stock market, with the Hang Seng Index falling below 24,000 points, reflecting increased macroeconomic risks and impacting market sentiment [1][4]. Market Performance - The Hang Seng Index closed down 1.06% at 23,892.32 points, with a total trading volume of 233.88 billion HKD. The Hang Seng China Enterprises Index fell 1.28%, while the Hang Seng Tech Index dropped 1.76% [1]. - Major blue-chip stocks experienced significant movements, with Henderson Land Development leading the decline, down 8.64% at 25.9 HKD, while China Biologic Products rose 10.06% to 5.91 HKD [2]. Sector Analysis - The technology sector saw a collective decline, with Alibaba down nearly 4% and Tencent over 1%. The copper sector was negatively impacted by Trump's tariff threats, leading to a drop in copper-related stocks [3][6]. - The innovative drug sector performed well, with Hengrui Medicine surging 15.61% to 69.6 HKD, indicating resilience amid broader market declines [3][4]. Specific Stock Movements - Macau's gaming sector showed strong performance, with Wynn Macau up 6.33% and Melco Resorts up 2.12%, driven by robust gaming revenue growth [4][5]. - Copper stocks faced significant declines, with Luoyang Molybdenum down 4.74% and Jiangxi Copper down 3.46%, reflecting market reactions to tariff announcements [5][6]. Commodity Prices - International gold prices fell below 3,300 USD per ounce, influenced by reduced safe-haven demand amid tariff uncertainties. Analysts expect gold prices to remain volatile within a range of 3,000 to 3,500 USD per ounce [7].

Group 1 - The Hang Seng Index fell by 0.74%, down 177 points, closing at 23,970 points, while the Hang Seng Tech Index dropped by 1.14% with a trading volume of HKD 122.4 billion in the morning session [1] - New weight stocks performed well, with CATL (03750) rising by 6.35%, reaching a new high since its listing after a strategic cooperation agreement with Geely [1] - Hengrui Medicine (01276) surged by 9.8%, hitting a new high after the clinical approval of SHR-2173 injection [2] Group 2 - Television Broadcasts (00511) increased by over 8% as the company deepens its strategic cooperation in the Greater Bay Area, with institutions optimistic about its profit outlook [3] - Fenbi (02469) rose by over 7% following a significant upgrade to its AI exam preparation system, expanding its AI product matrix [4] - China Rare Earth Holdings (03788) soared by 14%, with a year-to-date increase of 320%, as the company proposed to spin off its rare earth gold business for independent listing on the main board of the Hong Kong Stock Exchange [4] Group 3 - Hong Kong Travel (00308) continued to rise by 9%, doubling its stock price this year, driven by market speculation on stablecoin cross-border payment scenarios [5] - Q Technology (01478) increased by over 8%, with sales of mobile camera modules reaching 3.2648 million units in June, a year-on-year increase of 1.5% [6] - Gold stocks fell across the board as spot gold dropped below USD 3,300, with institutions predicting a high volatility trend for gold prices [6]

Key Points - The article highlights significant stock movements in the Hong Kong and US markets, with various companies experiencing notable gains and losses due to recent developments and announcements [1][2][3][4][5] Hong Kong Market Highlights - China Rare Earth Holdings (03788) surged nearly 20%, with a year-to-date increase of 320%, as the company proposed a spin-off of its gold segment for independent listing on the Hong Kong Stock Exchange [1] - Innovent Biologics (09969) rose nearly 4% after announcing the clinical approval of its new ADC innovative drug ICP-B794 [1] - North Sea Kangcheng - B (01228) increased over 50%, with its stock price doubling in three days, marking it as a rare disease stock in the Hong Kong market [1] - Hong Kong Travel (00308) saw a rise of over 24%, achieving a year-to-date stock price doubling, driven by market speculation on stablecoin cross-border payment scenarios [1] - CSPC Pharmaceutical Group (01093) gained nearly 3% after receiving drug registration approval for Mesalazine enteric-coated tablets, enhancing its product line in the immune system treatment sector [1] - Ruian Real Estate (00272) rose over 4%, with a cumulative contract property sales amount for the first six months increasing by 457% year-on-year [1] - Cornerstone Pharmaceuticals - B (02616) increased over 3%, planning to raise HKD 467 million for clinical research on CS2009 [1] - Q Technology (01478) rose over 7%, with mobile camera module sales of 32.648 million units in June, a year-on-year increase of 1.5% [1] - Dekang Agriculture and Animal Husbandry (02419) increased by 6%, with a new cycle logic continuing to strengthen, and Tianfeng Securities set a target price of HKD 154 [1] - Contemporary Amperex Technology (03750) rose over 3%, reaching a new high since its listing, following a deepened strategic cooperation agreement with Geely Automobile [2] - Gaming stocks continued to rise, with Wynn Macau (01128) up 6.49%, New World Development (00200) up 6.15%, and others showing similar gains [2] - Gold stocks faced declines, with Golden Resources (GORO.US) dropping nearly 10% and others following suit [4] US Market Highlights - Stablecoin concept stocks continued to rise, with Tiger Brokers (TIGR.US) increasing over 8% [4] - Trump Media & Technology Group (DJT.US) rose over 2% as the company seeks SEC approval for a blue-chip cryptocurrency ETF [4] - Wolfspeed (WOLF.US) continued to rise, with stock prices increasing over 9% [4] - Intel (INTC.US) rose over 7% after announcing company-wide layoffs [4] - JD.com (JD.US) increased over 2% as it launched its "Double Hundred Plan" for its delivery service [4]

Group 1 - The stock of Ningde Times (03750.HK) rose over 5%, surpassing 379 HKD, reaching a historical high [1]